On the basis of our preclinical data demonstrating that phosphodiesterase-@ ( PDE@ ) inhibition can modulate these cell populations , we evaluated whether the PDE@ inhibitor tadalafil can revert tumor-induced immunosuppression and promote tumor immunity in patients with HNSCC .